{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:31:47Z","timestamp":1794684707334,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82172833"],"award-info":[{"award-number":["No. 82172833"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of Hunan Province","award":["No.2019JJ50906, No. 2019JJ80030, No. 2018JJ2599, and No. 2020JJ4863"],"award-info":[{"award-number":["No.2019JJ50906, No. 2019JJ80030, No. 2018JJ2599, and No. 2020JJ4863"]}]},{"name":"the Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University","award":["No. YX202107"],"award-info":[{"award-number":["No. YX202107"]}]},{"name":"the Hunan Cancer Hospital Climb Plan","award":["No. 2020NSFC-A004"],"award-info":[{"award-number":["No. 2020NSFC-A004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous studies have shown that the N<jats:sup>6<\/jats:sup>-methyladenosine (m<jats:sup>6<\/jats:sup>A) modification enhances the binding ability of mRNAs\/long noncoding RNAs (lncRNAs) to microRNAs (miRNAs), but the impact of this modification on the competitive endogenous RNA (ceRNA) function of circular RNAs (circRNAs) is unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used a human circRNA microarray to detect the expression profiles of circRNAs in 3 pairs of cancer and paracancerous tissues from patients with colorectal cancer (CRC) and 3 pairs of peripheral blood specimens from patients with CRC and healthy individuals. The circRNAs highly expressed in both peripheral blood and tumour tissues of patients with CRC, including circALG1, were screened. A quantitative reverse-transcription polymerase chain reaction (qRT-PCR) analysis of an expanded sample size was performed to detect the expression level of circALG1 in peripheral blood and tumour tissues of patients with CRC and determine its correlation with clinicopathological features, and circRNA loop-forming validation and stability assays were then conducted. Transwell assays and a nude mouse cancer metastasis model were used to study the function of circALG1 in CRC and the role of altered m<jats:sup>6<\/jats:sup>A modification levels on the regulation of circALG1 function. qRT-PCR, western blot (WB), Transwell, RNA-binding protein immunoprecipitation (RIP), RNA antisense purification (RAP), and dual-luciferase reporter gene assays were performed to analyse the ceRNA mechanism of circALG1 and the effect of the m<jats:sup>6<\/jats:sup>A modification of circALG1 on the ceRNA function of this circRNA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CircALG1 was highly expressed in both the peripheral blood and tumour tissues of patients with CRC and was closely associated with CRC metastasis. CircALG1 overexpression promoted the migration and invasion of CRC cells, and circALG1 silencing and reduction of the circALG1 m<jats:sup>6<\/jats:sup>A modification level inhibited CRC cell migration and invasion. In vivo experiments further confirmed the prometastatic role of circALG1 in CRC. Further mechanistic studies showed that circALG1 upregulated the expression of <jats:italic>placental growth factor (PGF)<\/jats:italic> by binding to miR-342-5p and that m<jats:sup>6<\/jats:sup>A modification enhanced the binding of circALG1 to miR-342-5p and promoted its ceRNA function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>M<jats:sup>6<\/jats:sup>A modification enhances the binding ability of circALG1 to miR-342-5p to promote the ceRNA function of circALG1, and circALG1 could be a potential therapeutic target in and a prognostic marker for CRC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12943-022-01560-6","type":"journal-article","created":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T07:02:51Z","timestamp":1647673371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["The N6-methyladenosine modification of circALG1 promotes the metastasis of colorectal cancer mediated by the miR-342-5p\/PGF signalling pathway"],"prefix":"10.1186","volume":"21","author":[{"given":"Changwei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canbin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buning","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,19]]},"reference":[{"key":"1560_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"L Chen","year":"2020","unstructured":"Chen L. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1560_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, et al. The landscape of circular RNA in Cancer. Cell (Cambridge). 2019;176:869\u201381.","journal-title":"Cell (Cambridge)"},{"key":"1560_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clinbiochem.2019.10.012","volume":"74","author":"J Lin","year":"2019","unstructured":"Lin J, Cai D, Li W, Yu T, Mao H, Jiang S, et al. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer. Clin Biochem. 2019;74:60\u20138.","journal-title":"Clin Biochem"},{"key":"1560_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17:272\u201383.","journal-title":"Nat Rev Genet"},{"key":"1560_CR5","doi-asserted-by":"crossref","unstructured":"Long F, Lin Z, Li L, Ma M, Lu Z, Jing L, et al. Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer. Mol Cancer. 2021;20(1):26.","DOI":"10.1186\/s12943-021-01318-6"},{"key":"1560_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41419-018-0454-8","volume":"9","author":"K Zeng","year":"2018","unstructured":"Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T, et al. CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018;9:417.","journal-title":"Cell Death Dis"},{"key":"1560_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1085-0","volume":"19","author":"Y Chen","year":"2020","unstructured":"Chen Y, Lin Y, Shu Y, He J, Gao W. Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer. Mol Cancer. 2020;19:1\u201394.","journal-title":"Mol Cancer"},{"key":"1560_CR8","doi-asserted-by":"crossref","unstructured":"Xie J, Huang X, Chen Q, Ma Y, Zhao Y, Liu L, et al. m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling. Mol Cancer. 2020;19(1):114.","DOI":"10.1186\/s12943-020-01223-4"},{"key":"1560_CR9","doi-asserted-by":"crossref","unstructured":"Zhang X, Xu Y, Qian Z, Zheng W, Wu Q, Chen Y, et al. circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma. Cell Death Dis. 2018;9(11):1091.","DOI":"10.1038\/s41419-018-1132-6"},{"key":"1560_CR10","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1093\/nar\/gky130","volume":"46","author":"D Yang","year":"2018","unstructured":"Yang D, Qiao J, Wang G, Lan Y, Li G, Guo X, et al. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential. Nucleic Acids Res. 2018;46:3906\u201320.","journal-title":"Nucleic Acids Res"},{"key":"1560_CR11","doi-asserted-by":"crossref","unstructured":"Zhang L, Hou C, Chen C, Guo Y, Yuan W, Yin D, et al. The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs. Mol Cancer. 2020;19(1):105.","DOI":"10.1186\/s12943-020-01224-3"},{"key":"1560_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ebiom.2019.06.051","volume":"45","author":"D Li","year":"2019","unstructured":"Li D, Lin C, Li N, Du Y, Yang C, Bai Y, et al. PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness. Ebiomedicine. 2019;45:124\u201338.","journal-title":"Ebiomedicine"},{"key":"1560_CR13","doi-asserted-by":"crossref","unstructured":"Wu R, Li L, Bai Y, Yu B, Xie C, Wu H, et al. The long noncoding RNA LUCAT1 promotes colorectal cancer cell proliferation by antagonizing Nucleolin to regulate MYC expression. Cell Death Dis. 2020;11(10):908.","DOI":"10.1038\/s41419-020-03095-4"},{"key":"1560_CR14","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zeng P, Li Y, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44:e91.","journal-title":"Nucleic Acids Res"},{"key":"1560_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","volume":"21","author":"GJ Goodall","year":"2021","unstructured":"Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21:22\u201336.","journal-title":"Nat Rev Cancer"},{"key":"1560_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000493952","volume":"50","author":"M Qiao","year":"2018","unstructured":"Qiao M, Ding J, Yan J, Li R, Jiao J, Sun Q. Circular RNA expression profile and analysis of their potential function in psoriasis. Cell Physiol Biochem. 2018;50:15\u201327.","journal-title":"Cell Physiol Biochem"},{"key":"1560_CR17","doi-asserted-by":"crossref","unstructured":"Zou F, Cao D, Tang Y, Shu L, Zuo Z, Zhang L. Identification of CircRNA\u2013miRNA\u2013mRNA regulatory network in gastrointestinal stromal tumor. Front Genet. 2020;11:403.","DOI":"10.3389\/fgene.2020.00403"},{"key":"1560_CR18","doi-asserted-by":"crossref","unstructured":"Monsivais D, Vasquez YM, Chen F, Zhang Y, Chandrashekar DS, Faver JC, et al. Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers. Oncogene. 2021;40(11):2081-2095.","DOI":"10.1038\/s41388-021-01681-0"},{"key":"1560_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649\u201358.","journal-title":"Neoplasia"},{"key":"1560_CR20","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.4161\/auto.29190","volume":"10","author":"H-H Hou","year":"2014","unstructured":"Hou H-H, Cheng S-L, Chung K-P, Kuo MY-P, Yeh C-C, Chang B-E, et al. Elastase induces lung epithelial cell autophagy through placental growth factor: a new insight of emphysema pathogenesis. Autophagy. 2014;10:1509\u201321.","journal-title":"Autophagy"},{"key":"1560_CR21","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1182\/blood-2002-11-3423","volume":"102","author":"S Selvaraj","year":"2003","unstructured":"Selvaraj S, Giri R, Perelman N, Johnson C, Malik P, Kalra V. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood. 2003;102:1515\u201324.","journal-title":"Blood"},{"key":"1560_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","volume":"34","author":"AH Shain","year":"2018","unstructured":"Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T, et al. Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution. Cancer Cell. 2018;34:45\u201355.","journal-title":"Cancer Cell"},{"key":"1560_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-017-0684-x","volume":"16","author":"CSA Tutuka","year":"2017","unstructured":"Tutuka CSA, Andrews MC, Mariadason JM, Ioannidis P, Hudson C, Cebon J, et al. PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation. Mol Cancer. 2017;16:112.","journal-title":"Mol Cancer"},{"key":"1560_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/cr.2017.31","volume":"27","author":"Y Yang","year":"2017","unstructured":"Yang Y, Fan X, Mao M, Song X, Wu P, Zhang Y, et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 2017;27:626\u201341.","journal-title":"Cell Res"},{"key":"1560_CR25","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.celrep.2017.08.027","volume":"20","author":"C Zhou","year":"2017","unstructured":"Zhou C, Molinie B, Daneshvar K, Pondick JV, Wang J, Van Wittenberghe N, et al. Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs. Cell Rep (Cambridge). 2017;20:2262\u201376.","journal-title":"Cell Rep (Cambridge)"},{"key":"1560_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","volume":"76","author":"YG Chen","year":"2019","unstructured":"Chen YG, Chen R, Ahmad S, Verma R, Kasturi SP, Amaya L, et al. N6-Methyladenosine modification controls circular RNA immunity. Mol Cell. 2019;76:96\u2013109.","journal-title":"Mol Cell"},{"key":"1560_CR27","first-page":"1571","volume":"10","author":"D Wang","year":"2018","unstructured":"Wang D, Yang S, Wang H, Wang J, Zhang Q, Zhou S, et al. The progress of circular RNAs in various tumors. Am J Transl Res. 2018;10:1571.","journal-title":"Am J Transl Res"},{"key":"1560_CR28","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.2147\/OTT.S134403","volume":"10","author":"D Rong","year":"2017","unstructured":"Rong D, Tang W, Li Z, Zhou J, Shi J, Wang H, et al. Novel insights into circular RNAs in clinical application of carcinomas. Onco Targets Ther. 2017;10:2183\u20138.","journal-title":"Onco Targets Ther"},{"key":"1560_CR29","doi-asserted-by":"publisher","first-page":"e100836","DOI":"10.15252\/embj.2018100836","volume":"38","author":"IL Patop","year":"2019","unstructured":"Patop IL, W\u00fcst S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38:e100836.","journal-title":"EMBO J"},{"key":"1560_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12282-017-0793-9","volume":"25","author":"H Zhang","year":"2017","unstructured":"Zhang H, Jiang L, Sun D, Hou J, Ji Z. CircRNA: a novel type of biomarker for cancer. Breast Cancer (Tokyo, Japan). 2017;25:1\u20137.","journal-title":"Breast Cancer (Tokyo, Japan)"},{"key":"1560_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. Rna. 2013;19:141\u201357.","journal-title":"Rna"},{"key":"1560_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12943-020-01152-2","volume":"19","author":"G Liang","year":"2020","unstructured":"Liang G, Ling Y, Mehrpour M, Saw PE, Liu Z, Tan W, et al. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression. Mol Cancer. 2020;19:65.","journal-title":"Mol Cancer"},{"key":"1560_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li X, Yang L, Chen L. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71:428\u201342.","journal-title":"Mol Cell"},{"key":"1560_CR34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.18632\/oncotarget.652","volume":"3","author":"JA McCubrey","year":"2012","unstructured":"McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Montalto G, Cervello M, et al. Mutations and deregulation of Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR cascades which Alter therapy response. Oncotarget. 2012;3:954\u201387.","journal-title":"Oncotarget"},{"key":"1560_CR35","first-page":"4867","volume":"20","author":"S Zhao","year":"2019","unstructured":"Zhao S, Luo G, Wu H, Zhang L. Placental growth factor gene silencing mitigates the epithelial-to-mesenchymal transition via the p38 MAPK pathway in rats with hyperoxia-induced lung injury. Mol Med Rep. 2019;20:4867\u201374.","journal-title":"Mol Med Rep"},{"key":"1560_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/bcpt.12616","volume":"119","author":"L Zhang","year":"2016","unstructured":"Zhang L, Zhao S, Yuan L, Wu H, Jiang H, Luo G. Placental growth factor triggers epithelial-to-Mesenchymal transition-like changes in rat type II alveolar epithelial cells: activation of nuclear factor \u03baB Signalling pathway. Basic Clin Pharmacol. 2016;119:498\u2013504.","journal-title":"Basic Clin Pharmacol"},{"key":"1560_CR37","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","volume":"48","author":"T Liu","year":"2020","unstructured":"Liu T, Wei Q, Jin J, Luo Q, Liu Y, Yang Y, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res. 2020;48:3816\u201331.","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1186\/s12943-022-01571-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000}}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-022-01560-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-022-01560-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-022-01560-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T01:03:15Z","timestamp":1650589395000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-022-01560-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,19]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1560"],"URL":"https:\/\/doi.org\/10.1186\/s12943-022-01560-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12943-022-01571-3","asserted-by":"object"}]},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,19]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12943-022-01571-3","URL":"https:\/\/doi.org\/10.1186\/s12943-022-01571-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human tissues and clinical information were collected using protocols approved by the Ethics Committee of the Third Xiangya Hospital of Central South University. Written informed consent was obtained from each patient. All animal procedures used in the study were approved by the Animal Ethics Committee of Central South University and conducted according to the Guidelines for the Care and Use of Laboratory Animals at Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}